A complainant shared four third-party posts on X (formerly Twitter) and two online articles with the PMCPA to make the case ...

The U.S. Senate Finance Committee has voted to advance Robert F. Kennedy Jr.’s nomination for Secretary of Health and Human ...

Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...

Delving into the details, we found 51% of traders were bullish, while 25% showed bearish tendencies. Out of all the trades we ...

Moderna Inc (NASDAQ:MRNA) shares are trading lower Wednesday after Goldman Sachs downgraded the stock. Here's what you need ...

Goldman Sachs downgraded the vaccine maker to Neutral from Buy and slashed its stock-price target to $51 from $99 Wednesday.

The short explanation is that demand for Moderna's COVID-19 vaccine has plunged since the end of the pandemic. Moderna still has quite a bit of cash and some promising candidates. The main reason ...

Since then, though, Moderna has traveled along a rough path. Demand for the coronavirus vaccine has dropped significantly, and even the company's second approved product -- respiratory syncytial ...

The AstraZeneca and Johnson & Johnson vaccines were linked to a rare, but serious, blood clot in the brain and their use was restricted to certain groups. The Pfizer and Moderna jabs, meanwhile ...

There are currently three vaccine candidates moving through the clinical pipeline in human trials right now, and the furthest along is Moderna, which has developed a norovirus vaccine with the ...

Babies are supposed to receive vaccines that protect against about 15 different infectious diseases. Most require more than one dose, which amounts to nearly 30 jabs by age two. Parents may be ...